Soleno Therapeutics
SLNO
SLNO
18 hedge funds and large institutions have $20.5M invested in Soleno Therapeutics in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
7% less capital invested
Capital invested by funds: $22.2M → $20.5M (-$1.64M)
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$62K | |
| 2 | +$50.9K | |
| 3 | +$47K | |
| 4 |
SAM
Shikiar Asset Management
New York
|
+$43.5K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$33.1K |
Top Sellers
| 1 | -$66.2K | |
| 2 | -$47.2K | |
| 3 | -$42K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$30K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9K |